Literature DB >> 19568882

Pathology of mesothelioma.

Kouki Inai1.   

Abstract

The incidence of mesothelioma has been gradually increasing in Japan, and the underlying factor for this is considered to be the increase in the amount of asbestos imported into Japan between 1960 and 1975. Mesothelioma can be roughly divided into localized and diffuse types, but the former is extremely rare. In making a diagnosis of mesothelioma, it is important to confirm the location of tumor and the specific gross findings before histological examination. Mesothelioma can be categorized histologically as epithelioid type, sarcomatoid type, biphasic type, desmoplastic type, among others. It can take many forms; consequently, there are many diseases to be differentiated when the diagnosis of mesothelioma is based on histological analyses. Immunohistochemical stains are useful for making a diagnosis, but the correct combination of antibodies as positive or negative markers should be selected and a comprehensive assessment of the staining results is necessary. The accuracy of the pathological diagnosis is very important to the patients because they can be receive official compensation or relief when the diagnosis of mesothelioma is confirmed. Under present conditions, both clinicians and pathologists must make a concerted effort to improve the accuracy of the diagnosis of mesothelioma.

Entities:  

Year:  2008        PMID: 19568882      PMCID: PMC2698271          DOI: 10.1007/s12199-007-0017-6

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  22 in total

1.  Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institution.

Authors:  Daisuke Nonaka; Shigeki Kusamura; Dario Baratti; Paolo Casali; Antonello Domenico Cabras; Rami Younan; Juan Rosai; Marcello Deraco
Journal:  Cancer       Date:  2005-11-15       Impact factor: 6.860

2.  Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females.

Authors:  J H Shanks; M Harris; S S Banerjee; B P Eyden; V M Joglekar; A Nicol; P S Hasleton; A G Nicholson
Journal:  Am J Surg Pathol       Date:  2000-02       Impact factor: 6.394

3.  Primary intrathoracic synovial sarcoma: a clinicopathologic study of 40 t(X;18)-positive cases from the French Sarcoma Group and the Mesopath Group.

Authors:  Hugues Bégueret; Françoise Galateau-Salle; Louis Guillou; Bruno Chetaille; Elisabeth Brambilla; Jean-Michel Vignaud; Philippe Terrier; Odile Groussard; Jean-Michel Coindre
Journal:  Am J Surg Pathol       Date:  2005-03       Impact factor: 6.394

4.  Localized malignant mesothelioma.

Authors:  Timothy Craig Allen; Philip T Cagle; Andrew M Churg; Thomas V Colby; Allen R Gibbs; Samuel P Hammar; Joseph M Corson; Margaret M Grimes; Nelson G Ordonez; Victor Roggli; William D Travis; Mark R Wick
Journal:  Am J Surg Pathol       Date:  2005-07       Impact factor: 6.394

5.  D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.

Authors:  Nelson G Ordóñez
Journal:  Hum Pathol       Date:  2005-04       Impact factor: 3.466

6.  Value of estrogen and progesterone receptor immunostaining in distinguishing between peritoneal mesotheliomas and serous carcinomas.

Authors:  Nelson G Ordóñez
Journal:  Hum Pathol       Date:  2005-09-22       Impact factor: 3.466

7.  Malignant mesothelioma with a pronounced myxoid stroma: a clinical and pathological evaluation of 19 cases.

Authors:  Jinru Shia; Jing Qin; Robert A Erlandson; Roy King; Peter Illei; Jennifer Nobrega; Davis Yao; David S Klimstra
Journal:  Virchows Arch       Date:  2005-07-14       Impact factor: 4.064

8.  Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis.

Authors:  Patricia M Baker; Philip B Clement; Robert H Young
Journal:  Am J Clin Pathol       Date:  2005-05       Impact factor: 2.493

9.  Lymphohistiocytoid mesothelioma: a clinical, immunohistochemical and ultrastructural study of four cases and literature review.

Authors:  Davis X Yao; Jinru Shia; Robert A Erlandson; David S Klimstra
Journal:  Ultrastruct Pathol       Date:  2004 Jul-Aug       Impact factor: 1.094

10.  Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry.

Authors:  Kei Kushitani; Yukio Takeshima; Vishwa Jeet Amatya; Osamu Furonaka; Akio Sakatani; Kouki Inai
Journal:  Pathol Int       Date:  2008-02       Impact factor: 2.534

View more
  18 in total

1.  Largely Unchanged Annual Incidence and Overall Survival of Pleural Mesothelioma in the USA.

Authors:  Hari B Keshava; Andrew Tang; Hafiz Umair Siddiqui; Siva Raja; Daniel P Raymond; Alejandro Bribriesco; James Stevenson; Sudish C Murthy; Usman Ahmad
Journal:  World J Surg       Date:  2019-12       Impact factor: 3.352

2.  Pulmonary mesothelioma.

Authors:  Y E Tsai; S-F Huang; Shang-Tao Chien
Journal:  QJM       Date:  2016-05-19

Review 3.  Immunotherapy and radiation therapy for malignant pleural mesothelioma.

Authors:  Evan W Alley; Sharyn I Katz; Keith A Cengel; Charles B Simone
Journal:  Transl Lung Cancer Res       Date:  2017-04

4.  Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.

Authors:  Robert Ryan Meyerhoff; Chi-Fu Jeffrey Yang; Paul J Speicher; Brian C Gulack; Matthew G Hartwig; Thomas A D'Amico; David H Harpole; Mark F Berry
Journal:  J Surg Res       Date:  2015-01-29       Impact factor: 2.192

5.  Clinical Features and Outcomes of Tunica Vaginalis Mesothelioma: A Case Series From the National Institutes of Health.

Authors:  Julie Y An; David Kim; Sally Tanakchi; Alice M Semerjian; Anish Thomas; Shawna L Boyle; Raffit Hassan; Adam R Metwalli
Journal:  Clin Genitourin Cancer       Date:  2017-05-22       Impact factor: 2.872

6.  Desmoplastic malignant mesothelioma of the peritoneum.

Authors:  Bartu Badak; Ozgur Turk; Ersin Ates; Deniz Arik
Journal:  Oxf Med Case Reports       Date:  2014-06-14

Review 7.  Orotate phosphoribosyltransferase is overexpressed in malignant pleural mesothelioma: Dramatically responds one case in high OPRT expression.

Authors:  Yoichiro Hamamoto; Shinjiro Takeoka; Atsuto Mouri; Munehisa Fukusumi; Kazushige Wakuda; Tatsuya Ibe; Chie Honma; Yoshihito Arimoto; Kazuaki Yamada; Miyuki Wagatsuma; Akito Tashiro; Shingo Kamoshida; Mitsuhiro Kamimura
Journal:  Rare Dis       Date:  2016-04-05

8.  Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma.

Authors:  Frances E Lennon; Gianguido C Cianci; Rajani Kanteti; Jacob J Riehm; Qudsia Arif; Valeriy A Poroyko; Eitan Lupovitch; Wickii Vigneswaran; Aliya Husain; Phetcharat Chen; James K Liao; Martin Sattler; Hedy L Kindler; Ravi Salgia
Journal:  Sci Rep       Date:  2016-04-15       Impact factor: 4.379

9.  CLDN15 is a novel diagnostic marker for malignant pleural mesothelioma.

Authors:  Masayuki Watanabe; Tomohito Higashi; Kana Ozeki; Atsuko Y Higashi; Kotaro Sugimoto; Hayato Mine; Hironori Takagi; Yuki Ozaki; Satoshi Muto; Naoyuki Okabe; Yuki Matsumura; Takeo Hasegawa; Yutaka Shio; Hiroyuki Suzuki; Hideki Chiba
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

10.  Establishment of anti-mesothelioma monoclonal antibodies.

Authors:  Natsuko Mizutani; Masaaki Abe; Shuji Matsuoka; Kazunori Kajino; Midori Wakiya; Naomi Ohtsuji; Ryo Hatano; Chikao Morimoto; Okio Hino
Journal:  BMC Res Notes       Date:  2016-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.